RECOVER researchers shared how the prescription drug metformin may reduce the risk of Long COVID and presented research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after a […]
Metformin and Long COVID: Rethinking an Old Drug for a New Syndrome
By John Murphy, The COVID-19 Long-haul Foundation As the global medical community continues to grapple with the aftermath of the COVID-19 pandemic, one of its most elusive challenges remains long […]
COVID Long-Haul Illnesses: Five Years of Recovery, Research, and Hope
Five years after the global onset of COVID-19, long-haul illnesses—collectively known as long COVID—remain a complex and evolving public health challenge. Affecting millions worldwide, long COVID is now recognized as […]
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Suo-wen Xu, Iqra Ilyas & Jian-ping Weng Acta Pharmacologica Sinica volume 44, pages695–709 (2023) Nature Abstract The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute […]